Back to Search
Start Over
Consideration-of-concept of EvolvRehab-Body for upper limb virtual rehabilitation at home for people late after stroke.
- Source :
-
Physiotherapy [Physiotherapy] 2022 Sep; Vol. 116, pp. 97-107. Date of Electronic Publication: 2022 Apr 09. - Publication Year :
- 2022
-
Abstract
- Objective: EvolvRehab-Body is a non-immersive virtual rehabilitation system that could provide high-dose, exercise-based upper limb therapy after stroke. This consideration-of-concept study investigated: adherence rate to prescribed repetitions; viability of repeated measures in preparation for a dose-articulation study; and preliminary signal of potential benefit.<br />Methods: Pre-post and repeated measures with people at least six months after stroke. Twelve-week intervention: exercise-based therapy via EvolvRehab-Body. Pre-post-intervention measures: Wolf Motor Function Test (WMFT); hand grip force. Repeated-during-intervention measures: Motricity Index (MI) and Action Research Arm Test (ARAT).<br />Analysis: adherence rate (%) to set repetitions; percentage of total possible measures collected; pre-to-post-intervention change estimated in relation to published minimally detectable changes of WMFT and hand grip force; and slope of plotted data for MI and ARAT (linear regression).<br />Results: Eight of twelve participants completed the 12-week intervention phase. Adherence: 88% (1710-9377 repetitions performed). Viability repeated measures: 88 of 96 (92%) ARAT and MI scores collected. Preliminary signal of potential benefit was observed in five participants but not always for the same measures. Three participants improved WMFT-time (-7.9 to -27.2 s/item), four improved WMFT-function (0.2-1.1 points/item), and nobody changed grip force. Slope of plotted data over the 12-week intervention ranged from: - 1.42 (p = 0.26) to 1.36 (p = 0.24) points-per-week for MI and - 0.30 (p = 0.40) to 1.71 (p < 0.001) points-per-week for ARAT.<br />Conclusion: Findings of good adherence rate in home settings and preliminary signal of benefit for some participants gives support to proceed to a dose-articulation study. These findings cannot inform clinical practice. CONTRIBUTION OF THE PAPER.<br />Competing Interests: Declaration of Competing Interest Evolv Rehabilitation Technologies provided part-funding of the University of East Anglia PhD studentship held by Fiona Ellis, first author of this scientific report. This funding was provided without involvement of Evolv Rehabilitation Technologies in the project or writing of the scientific report.<br /> (Copyright © 2022 Chartered Society of Physiotherapy. Published by Elsevier Ltd. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1873-1465
- Volume :
- 116
- Database :
- MEDLINE
- Journal :
- Physiotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 35605564
- Full Text :
- https://doi.org/10.1016/j.physio.2022.03.004